U.S. FDA issues guidance to support the development of nanotechnology products

The U.S. Food and Drug Administration (FDA) has issued three final guidances and one draft guidance providing greater regulatory clarity for industry on the use of nanotechnology in FDA-regulated products.
IFT Daily News